• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease.胃肠道移植物抗宿主病中的炎症细胞因子网络。
Front Immunol. 2019 Feb 22;10:163. doi: 10.3389/fimmu.2019.00163. eCollection 2019.
2
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Host Disease.用于预防胃肠道移植物宿主病的转化临床策略。
Front Immunol. 2021 Nov 26;12:779076. doi: 10.3389/fimmu.2021.779076. eCollection 2021.
3
The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.黏膜相关不变 T 细胞在造血干细胞移植后肠道移植物抗宿主病发病机制中的潜在作用。
Front Immunol. 2021 Sep 3;12:720354. doi: 10.3389/fimmu.2021.720354. eCollection 2021.
4
Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.阻断供体移植物上的 TIM-1 可改善造血细胞移植后的移植物抗宿主病。
Blood Adv. 2019 Nov 12;3(21):3419-3431. doi: 10.1182/bloodadvances.2019000286.
5
MAGIC biomarkers of acute graft-versus-host disease: Biology and clinical application.急性移植物抗宿主病的 MAGIC 标志物:生物学和临床应用。
Best Pract Res Clin Haematol. 2019 Dec;32(4):101111. doi: 10.1016/j.beha.2019.101111. Epub 2019 Oct 18.
6
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.白细胞介素-33/ST2轴在急性移植物抗宿主病期间增强效应T细胞反应。
Blood. 2015 May 14;125(20):3183-92. doi: 10.1182/blood-2014-10-606830. Epub 2015 Mar 26.
7
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
8
T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.T-bet通过调节小鼠受体造血细胞促进急性移植物抗宿主病
J Immunol. 2016 Apr 1;196(7):3168-79. doi: 10.4049/jimmunol.1501020. Epub 2016 Feb 22.
9
Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.急性移植物抗宿主病的发病机制:细胞因子与细胞效应器
J Hematother Stem Cell Res. 2000 Jun;9(3):299-306. doi: 10.1089/15258160050079407.
10
Acute graft-vs-host disease: pathobiology and management.急性移植物抗宿主病:病理生物学与管理
Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9.

引用本文的文献

1
A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients.一项关于造血干细胞移植患者使用β受体阻滞剂及其预后的回顾性研究。
PeerJ. 2025 Aug 8;13:e19822. doi: 10.7717/peerj.19822. eCollection 2025.
2
A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.白细胞介素-2与白细胞介素-4的比例较高可能是异基因造血干细胞移植后急性移植物抗宿主病的早期预测指标。
Front Immunol. 2025 Jul 11;16:1620761. doi: 10.3389/fimmu.2025.1620761. eCollection 2025.
3
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipients.异基因造血细胞移植受者静脉补充维生素C的可行性
EJHaem. 2024 Aug 27;5(5):1043-1047. doi: 10.1002/jha2.995. eCollection 2024 Oct.
4
Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation - the Karolinska experience.与在医院隔离相比,接受同种异体造血细胞移植的患者在家庭护理中接受治疗具有更好的临床结局和更低的炎症细胞因子触发率 - 卡罗林斯卡经验。
Front Immunol. 2024 Aug 7;15:1384137. doi: 10.3389/fimmu.2024.1384137. eCollection 2024.
5
Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?移植物抗宿主病:生物标志物能否辅助鉴别诊断、预后评估及治疗策略制定?
Pharmaceuticals (Basel). 2024 Feb 26;17(3):298. doi: 10.3390/ph17030298.
6
Regulation of the Nur77-P2X7r Signaling Pathway by Nodakenin: A Potential Protective Function against Alcoholic Liver Disease.Nodakenin 通过调控 Nur77-P2X7r 信号通路对酒精性肝病发挥潜在的保护作用。
Molecules. 2024 Feb 29;29(5):1078. doi: 10.3390/molecules29051078.
7
Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.胎盘来源的蜕膜基质细胞:急性移植物抗宿主病治疗的新前沿。
Stem Cells. 2024 Apr 15;42(4):291-300. doi: 10.1093/stmcls/sxae003.
8
Intravenous Vitamin C Supplementation in Allogeneic Hematopoietic Cell Transplant Recipients: Salutary Impact on Clinical Outcomes.异基因造血细胞移植受者静脉补充维生素C:对临床结局的有益影响。
Res Sq. 2023 Nov 10:rs.3.rs-3538792. doi: 10.21203/rs.3.rs-3538792/v1.
9
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.供者 T 细胞中半乳糖凝集素-3 的表达可降低异基因造血细胞移植后移植物抗宿主病的严重程度和致死率。
Cell Rep. 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15.
10
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease.可药物化的转录因子 Fli-1 调控移植物抗宿主病中的 T 细胞免疫和耐受。
J Clin Invest. 2022 Nov 1;132(21):e143950. doi: 10.1172/JCI143950.

本文引用的文献

1
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells.移植物抗宿主病而非移植物抗白血病免疫由 GM-CSF 许可的髓系细胞介导。
Sci Transl Med. 2018 Nov 28;10(469). doi: 10.1126/scitranslmed.aat8410.
2
From proteomics to discovery of first-in-class ST2 inhibitors active in vivo.从蛋白质组学到发现体内有效的首创类 ST2 抑制剂。
JCI Insight. 2018 Jul 26;3(14). doi: 10.1172/jci.insight.99208.
3
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.托珠单抗治疗重症类固醇难治性急性移植物抗宿主病下消化道。
Bone Marrow Transplant. 2019 Feb;54(2):212-217. doi: 10.1038/s41409-018-0236-z. Epub 2018 May 24.
4
Redefining the ancestral origins of the interleukin-1 superfamily.重新定义白细胞介素-1 超家族的祖先起源。
Nat Commun. 2018 Mar 20;9(1):1156. doi: 10.1038/s41467-018-03362-1.
5
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.MAGIC 标志物可预测激素耐药性急性移植物抗宿主病的长期结局。
Blood. 2018 Jun 21;131(25):2846-2855. doi: 10.1182/blood-2018-01-822957. Epub 2018 Mar 15.
6
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.BATF 依赖性 IL-7RhiGM-CSF+ T 细胞控制肠道移植物抗宿主病。
J Clin Invest. 2018 Mar 1;128(3):916-930. doi: 10.1172/JCI89242. Epub 2018 Jan 29.
7
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft--host disease: low incidence of lower gastrointestinal tract disease.托珠单抗、他克莫司和甲氨蝶呤预防急性移植物抗宿主病:下消化道疾病发生率低。
Haematologica. 2018 Apr;103(4):717-727. doi: 10.3324/haematol.2017.183434. Epub 2018 Jan 19.
8
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.白细胞介素-33(IL-33):IL-1 家族的一种核细胞因子。
Immunol Rev. 2018 Jan;281(1):154-168. doi: 10.1111/imr.12619.
9
IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation.白细胞介素-12/23p40 中和阻断异基因造血细胞移植后的 Th1/Th17 反应。
Haematologica. 2018 Mar;103(3):531-539. doi: 10.3324/haematol.2017.171199. Epub 2017 Dec 14.
10
Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.肠道急性移植物抗宿主病:胃肠病学家需考虑的因素
Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):711-726. doi: 10.1038/nrgastro.2017.126. Epub 2017 Sep 27.

胃肠道移植物抗宿主病中的炎症细胞因子网络。

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease.

机构信息

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.

Department of Medicine, Bone Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI, United States.

出版信息

Front Immunol. 2019 Feb 22;10:163. doi: 10.3389/fimmu.2019.00163. eCollection 2019.

DOI:10.3389/fimmu.2019.00163
PMID:30853956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6395399/
Abstract

Graft vs. host disease (GVHD) is the major non-relapse complication associated with allogeneic hematopoietic stem cell transplantation (HSCT). Damage to the gastrointestinal (GI) tract from acute GVHD is a particularly serious event that can result in significant morbidity and mortality. Proinflammatory cytokines play a critical role in the pathophysiology of intestinal GVHD, in part by activating donor T cell populations which subsequently induce tissue damage. In this review, we summarize pre-clinical data derived from experimental murine models that have examined the role of inflammatory cytokine pathways that play critical roles in the pathophysiology of GVHD of the GI tract. Specific areas of focus are on STAT 3-dependent cytokines (e.g., IL-6, IL-23, and IL-21), and members of the IL-1 cytokine family, both of which have been shown to induce pathological damage within the GI tract during this disease. We also review established and ongoing efforts to translate these pre-clinical findings into the clinic in an effort to reduce morbidity and mortality due to this complication.

摘要

移植物抗宿主病(GVHD)是与异基因造血干细胞移植(HSCT)相关的主要非复发并发症。急性 GVHD 对胃肠道(GI)的损害是一个特别严重的事件,可导致显著的发病率和死亡率。促炎细胞因子在肠道 GVHD 的病理生理学中起着关键作用,部分原因是通过激活供体 T 细胞群,随后诱导组织损伤。在这篇综述中,我们总结了来源于实验性小鼠模型的临床前数据,这些数据研究了在胃肠道 GVHD 的病理生理学中起关键作用的炎症细胞因子途径的作用。重点关注的领域是 STAT3 依赖性细胞因子(例如,IL-6、IL-23 和 IL-21)和 IL-1 细胞因子家族的成员,在这种疾病中,这两者都被证明会在胃肠道内引起病理性损伤。我们还回顾了将这些临床前发现转化为临床实践的既定和正在进行的努力,以降低这种并发症的发病率和死亡率。